# Ilant Health

> Ilant Health is a New York healthcare company that helps employers and health plans identify people at high cardiometabolic risk, match them with individualized obesity treatment, and support them through a multidisciplinary clinical team. Its wager is that better routing - across behavioral care, nutrition, medication and bariatric surgery - can improve health while controlling the total cost of care.

- **Founded:** 2022
- **Headquarters:** New York, United States
- **Founders:** Elina Onitskansky (Founder and CEO)
- **Products:** Ilant Rapid Returns (IRR), Ilant Metabolism Matters (IMM), Ilant App, Comprehensive obesity and cardiometabolic care, Value-Based Care Services
- **Notable:** Raised a $15 million Series A in June 2026 and reported more than $22 million in total funding., Built nationwide employer and health-plan availability across all 50 US states., Selected as an administrator in Eli Lilly's Employer Connect launch.

## Products & services

- **Ilant Rapid Returns (IRR)** — A proprietary AI and machine-learning risk stratification engine used to identify higher-risk members most likely to benefit from proactive care.
- **Ilant Metabolism Matters (IMM)** — An AI-supported clinical decision tool that combines clinical, behavioral and individual factors to recommend an evidence-based treatment path.
- **Ilant App** — A member app for communication, scheduling, health tracking and connected-device data that gives the care team signals for timely intervention.
- **Comprehensive obesity and cardiometabolic care** — A virtual, multidisciplinary service spanning lifestyle change, anti-obesity medication, behavioral health, nutrition, peer navigation, condition management and bariatric surgery referral.
- **Value-Based Care Services** — Population analysis, benefit design support, targeted member engagement and outcomes measurement for employers and health plans.

## Achievements

- Raised a $15 million Series A in June 2026 and reported more than $22 million in total funding.
- Built nationwide employer and health-plan availability across all 50 US states.
- Selected as an administrator in Eli Lilly's Employer Connect launch.
- Reports 15% average one-year weight reduction, 50% biometric remission and 2-4x in-year ROI on its current website; these are company-reported figures.
- An Ilant case study with SEIU 775 Benefits Group reports 10% weight loss and more than 50% biometric improvement among engaged members after six months.
- Received recognition from EHIR and participated in the AlphaLab Health accelerator.

## Latest updates

- **2026-09** — CEO Elina Onitskansky framed the market as a treatment-matching and clinical-support problem in a CB Insights interview.
- **2026-06** — Raised a $15 million Series A led by Cornucopian Capital to expand its AI-supported precision-care model.
- **2026-03** — Joined the launch group of independent program administrators for Lilly Employer Connect.
- **2025-11** — Announced direct contracting and transparent pricing for Eli Lilly obesity medicines for employers, beginning in early 2026.
- **2024-11** — Partnered with Galway Holdings on an obesity and cardiometabolic Center of Excellence for employees and employer clients.
- **2024-04** — Extended its seed round from $3 million to $5.5 million.

## Links

- Website: https://www.ilanthealth.com
- LinkedIn: https://www.linkedin.com/company/ilant-health

---

Profile page: https://yespress.io/ilant-health
Published by YesPress — https://yespress.io
Last updated: 2026-09-26